Aims and Scope
Journal of Hematology & Thromboembolic Diseases brings articles related to Anemia, Iron Therapy, Pulmonary embolism, Leukemia, Sickle cell Disease, Haemoglobin.
Discussions on various diseases and their treatments like macrophages, Bone marrow Disease, Blood Clot, Immunoglobulins, Dendritic Cells, Myeloproliferative Disorders, Prothrombin Time.
The journal also brings you articles in the fields of Thromboembolism, Laboratory Haemostasis, Melanoma, Polycythemia Vera.
Journal of Hematology & Thromboembolic Diseases brings articles related to Thrombocythemia, Anticoagulant Drugs, Lymph, Sickle erythrocytes, B-cell Lymphoma, Myelogenous Leukemia, etc.
Journal of Hematology & Thromboembolic Diseases is a broad-based journal found on two key tenets: To publish the most exciting researches related to Hematology & Thromboembolic Diseases: Second to provide a rapid turn-around time possible for reviewing and publishing of articles freely for research, teaching and reference purposes.
It is basically aimed at the Clinical Practitioners, medical/ health practitioners, students, professionals and researchers, and professional bodies and institutions.
All works published by Longdom Publishing SL are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work, provided the original work and source is appropriately cited. Journal of Hematology & Thromboembolic Diseases strongly supports the Open Access initiative. All the published articles will be assigned DOI provided by Cross Ref. The journal updates the latest advancements in the field of Hematology & Thromboembolic Diseases. Abstracts and full texts (HTML, PDF and XML format) of all articles published by this journal are freely accessible to everyone immediately after publication. Journal of Hematology & Thromboembolic Diseases supports the Bethesda Statement on Open Access Publishing.